Bilada Bilican is an experienced professional in the field of BioPharma R&D, currently serving as Director at AstraZeneca since December 2020. Prior to this role, Bilada was the Discovery Biology Lead and Senior Principal Scientist at Vesalius Therapeutics from May 2019 to December 2020, and held positions as Investigator and project team lead in the Neurodegeneration group at Novartis Institutes for BioMedical Research from August 2014 to April 2019. Bilada's postdoctoral research includes fellowships at the MRC Centre for Regenerative Medicine at the University of Edinburgh and the Cambridge Centre for Brain Repair, focusing on neurodegenerative disease modeling and cellular biology. Bilada earned a PhD in Oncology and Cancer Biology from the University of London, along with an MSc in Molecular Biology and Genetics from Bilkent University. Additional academic credentials include a BSc in Industrial Engineering and a minor in Biology from Middle East Technical University.
This person is not in any teams
This person is not in any offices